Literature DB >> 1234014

Intravenous infusion of salbutamol in the treatment of asthma.

S G Spiro, A J Johnson.   

Abstract

The effects of i.v. infusion of increasing rates of salbutamol for up to 4 h were documented in ten convalescent asthmatic patients. 2 The major bronchodilator effect was seen at 4.16 mug/minute. A small further improvement occurred at infusion rates up to 25.0 mug/min but was not significantly better than that seen at the lower infusion rate. 3 Cardiovascular effects were minimal after 60 min at the lower rate and even at 25.0 mug/min mean heart rate rose by only 17.1 beats/minute. All patients tolerated the 4 h infusion well. 4 It is concluded that i.v. infusion of salbutamol may be a useful addition to the treatment of the patient with a severe attack of asthma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1234014      PMCID: PMC1402645          DOI: 10.1111/j.1365-2125.1975.tb00567.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  Mutal suppression of cardiovascular effects of some beta-adrenoreceptor agonists in the cat.

Authors:  J M Atkinson; M J Rand
Journal:  J Pharm Pharmacol       Date:  1968-12       Impact factor: 3.765

2.  Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity.

Authors:  A E Tattersfield; M W McNicol
Journal:  N Engl J Med       Date:  1969-12-11       Impact factor: 91.245

3.  Isoprenaline-induced tachycardia in man.

Authors:  P J Kingsley; D W Littlejohns; B N Prichard
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

4.  The clinical pharmacology of oral and inhaled salbutamol.

Authors:  S R Walker; M E Evans; A J Richards; J W Paterson
Journal:  Clin Pharmacol Ther       Date:  1972 Nov-Dec       Impact factor: 6.875

5.  Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.

Authors:  D A Warrell; D G Robertson; J N Howes; M E Conolly; J W Paterson; L J Beilin; C T Dollery
Journal:  Br Med J       Date:  1970-01-10

6.  Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticus.

Authors:  T E Van Metre
Journal:  J Allergy       Date:  1969-02

7.  Haemodynamic effects of intravenous salbutamol in patients with mitral valve disease: comparison with isoprenaline and atropine.

Authors:  D G Gibson; D J Coltart
Journal:  Postgrad Med J       Date:  1971-03       Impact factor: 2.401

8.  Intravenous infusion of salbutamol in the management of premature labour.

Authors:  G C Liggins; G S Vaughan
Journal:  J Obstet Gynaecol Br Commonw       Date:  1973-01

9.  Iatrogenic asthma associated with adrenergic aerosols.

Authors:  J F Keighley
Journal:  Ann Intern Med       Date:  1966-11       Impact factor: 25.391

10.  Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation.

Authors:  Y F Choo-Kang; S S Parker; I W Grant
Journal:  Br Med J       Date:  1970-11-21
View more
  3 in total

1.  Characterization of beta-adrenoceptor subtype mediating the metabolic actions of salbutamol.

Authors:  N Berend; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

2.  Slow-release oral salbutamol and aminophylline in nocturnal asthma: relation of overnight changes in lung function and plasma drug levels.

Authors:  A J Fairfax; W R McNabb; H J Davies; S G Spiro
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

3.  Cardiovascular response during severe acute asthma and its treatment in children.

Authors:  A T Edmunds; S Godfrey
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.